Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al
Saved in:
| Title: | Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al |
|---|---|
| Authors: | Sinclair, Rodney1, Mesinkovska, Natasha2, Mitra, Debanjali3, Wajsbrot, Dalia3, Law, Ernest H.3 ernest.law@pfizer.com, Wolk, Robert4, King, Brett5 |
| Source: | American Journal of Clinical Dermatology. Jan2025, Vol. 26 Issue 1, p109-119. 11p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
